Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shree Ganesh Biotech (India) Ltd has informed the stock exchanges that the trading window for dealing in its securities will be closed from Thursday, 1st January 2026 until 48 hours after the declaration of its Unaudited Financial Results for the quarter ended 31st December 2025. This is a routine compliance step under SEBI's Insider Trading Regulations, preventing insiders like directors, officers, and employees from trading in company shares while they may have access to unpublished financial results. The date of the Board Meeting to approve the Q3 FY26 results will be communicated later.
This is a standard regulatory filing and does not affect share price. It simply restricts insiders from trading until quarterly results are announced, which is normal practice before earnings disclosure.